Cronos Group Inc. (CRON) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
CRON currently has 379M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 1.32% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 11, 2026 |
10-Q filing | 379.4M shares outstanding |
380M | 0 |
| Nov 06, 2025 |
10-Q filing | 383.1M shares outstanding |
380M | 0 |
| Aug 07, 2025 |
10-Q filing | 385.3M shares outstanding |
390M | 0 |
| May 08, 2025 |
10-Q filing | 387.0M shares outstanding |
390M | 0 |
| May 08, 2025 |
8-K filing: On May 8, 2025, the Company announced that its Board of Directors authorized a share repurchase program of up to $50 million. Open market purchases will not exceed 19,270,951 shares, being 5% of the outstanding common shares as of May 7, 2025. ($50.0M proceeds) |
380M | 0 |
| Feb 27, 2025 |
10-K filing | 382.1M shares outstanding |
380M | 0 |
| Nov 12, 2024 |
10-Q filing | 382.3M shares outstanding |
380M | 0 |
| Aug 08, 2024 |
10-Q filing | 382.2M shares outstanding |
380M | 0 |
| May 09, 2024 |
10-Q filing | 381.4M shares outstanding |
380M | 0 |
| Feb 29, 2024 |
10-K filing | 381.0M shares outstanding |
380M | 0 |
| Nov 08, 2023 |
10-Q filing | 381.1M shares outstanding |
380M | 0 |
| Aug 08, 2023 |
10-Q filing | 381.0M shares outstanding |
380M | 0 |
| May 09, 2023 |
10-Q filing | 380.6M shares outstanding |
380M | 0 |
| Feb 28, 2023 |
10-K filing | 377.0M shares outstanding |
380M | 0 |
| Dec 19, 2022 |
8-K filing: Altria Group Inc. notified Cronos Group Inc. that its wholly-owned subsidiary, Altria Summit LLC, relinquished a warrant to subscribe for and purchase up to 84,243,223 common shares of the Company at a per share exercise price of C$19.00 for no consideration, and Altria continues to beneficially own 156,573,537 common shares of the Company. |
160M | 0 |
| Nov 07, 2022 |
10-Q filing | 378.1M shares outstanding |
380M | 0 |
| Aug 09, 2022 |
10-Q filing | 376.0M shares outstanding |
380M | 0 |
| May 10, 2022 |
10-Q filing | 375.0M shares outstanding |
380M | 0 |
| Mar 01, 2022 |
10-K filing | 370.4M shares outstanding |
370M | 0 |
| Feb 18, 2022 |
10-Q filing | 375.7M shares outstanding |
380M | 0 |
| Aug 06, 2021 |
10-Q filing | 371.7M shares outstanding |
370M | 0 |
| Jun 15, 2021 |
8-K filing: Cronos USA purchased an option to acquire 473,787 shares of Class A Common Stock of PharmaCann for approximately $110.4 million on June 14, 2021. ($110.4M proceeds) |
360M | 0 |
| Jun 04, 2021 |
8-K filing: Cronos Group Inc. entered into an Amended and Restated Collaboration and License Agreement with Ginkgo Bioworks, Inc., modifying the terms for issuing common shares to Ginkgo upon achieving certain milestones related to cannabinoid production. |
360M | 0 |
| May 07, 2021 |
10-Q filing | 363.0M shares outstanding |
360M | 0 |
| Feb 26, 2021 |
10-K filing | 351.6M shares outstanding |
350M | 0 |
| Nov 05, 2020 |
10-Q filing | 350.3M shares outstanding |
350M | 0 |
| Aug 06, 2020 |
10-Q filing | 349.1M shares outstanding |
350M | 0 |
| May 08, 2020 |
10-Q filing | 348.8M shares outstanding |
350M | 0 |